Medica RCP |Sevoflurane* | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Sevoflurane*

Contraindicated
Reproductive toxicity in animals

May be acceptable
Use with caution

Sevoflurane* :
Type	Medicine Non Marketed
Originator	B
Agent	Interpharma
Distributor	Interpharma
Laboratory	AbbVie
Responsible Party	Abbvie Ltd
Origin	UK
Manufacturer	Aesica Queenborough Ltd
Origin	UK
ATC	N01AB08
Revision Date	01/10/2014

Sevoflurane* :

Inhalation

Sevoflurane* :

N Nervous System

N01 Anesthetics

N01A General anesthetics

N01AB Halogenated hydrocarbons

N01AB08 sevoflurane

Sevoflurane* :

Sevoflurane : 100%

Sevoflurane* :

Adults : General anaesthetic 5%

Sevoflurane* :

Water for injections

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Sevoflurane* :

Revision Date : 06/11/2015

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Agitation	Very Common
ALT increased	Uncommon
Anaphylactic reactions	Not known
Anaphylactoid reactions	Not known
Apnoea (Apnea)	Uncommon
Arrhythmia	Uncommon
AST increased	Common
Asthma	Uncommon
Atrial fibrillation	Uncommon
Atrioventricular block complete	Uncommon
Blood creatinine increased	Uncommon
Blood glucose abnormal	Common
Blood lactate dehydrogenase increased	Uncommon
Bradycardia	Very Common
Bronchospasm	Not known
Cardiac arrest	Not known
Chest discomfort	Not known
Chills	Common
Confusional state	Uncommon
Convulsion	Not known
Cough	Very Common
Dermatitis contact	Not known
Dizziness	Not known
Dyspnoea (dyspnea)	Not known
Dystonia	Not known
Extrasystoles	Not known
Fluoride increased	Common
Glucosuria (Glycosuria)	Not known
Headache	Not known
Hepatic failure (Hepatic insufficiency) (Liver failure)	Not known
Hepatic necrosis	Not known
Hepatitis	Not known
Hypersensitivity	Not known
Hypertension	Common
Hypotension	Very Common
Hypothermia	Common
Hypoxia	Uncommon
Laryngospasm	Common
Leucopenia (Leukopenia)	Not known
Leukocytosis	Not known
Liver function test abnormal	Common
Malignant hyperthermia	Not known
Muscle twitching (Muscle twitch)	Not known
Nausea	Very Common
Pruritus	Not known
Pulmonary oedema	Not known
Pyrexia	Common
QT interval prolonged (QT prolongation)	Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute)	Not known
Respiratory disorder	Common
Salivary hypersecretion	Common
Skin rash	Not known
Somnolence	Common
Supraventricular extrasystoles	Uncommon
Swelling face	Not known
Tachycardia	Common
Torsade de pointes	Not known
Urinary retention	Uncommon
Urticaria	Not known
Ventricular extrasystoles	Uncommon
Vomiting	Common
Wheezing	Not known
White blood cell count abnormal	Common

Sevoflurane* :

Abu Dhabi

Bahrain

Cyprus

Finland

France

Germany

Greece

Iceland

Italy

Jordan

KSA

Kuweit

Norway

Oman

Qatar

Spain

The Netherlands

Turkey

UAE

Medicine Authorised

Sevoflurane

Interpharma

AbbVie

Medicine Authorised

Sojourn

Major Pharma Drugstore

Piramal Critical Care

Medicine Authorised

Suprane

Abela Freres

Baxter

NB : Products With Same Indication

Coming Very Soon

Different Units By MoH Code

Revision Date : 01/10/2014

Sevoflurane* MoH 3375 :

Form Inhalation vapour, liquid

Packaging Bottle

Package Size 250ml

Strength 100%

Storage Condition <25°C Away from moisture

NSSF ✘

Quarantine ✘

Reg. Number 261331

Submission date 01/01/1997

Registration Year 1997

Archived Date 12/12/2022

Price Comparison

You have to register to view this info

Note

You have to register to view this info

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Inhalation vapour, liquid
Packaging	Bottle
Package Size	250ml
Strength	100%
Storage Condition	<25°C Away from moisture
NSSF	✘
Quarantine	✘
Reg. Number	261331
Submission date	01/01/1997
Registration Year	1997
Archived Date	12/12/2022